Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer

Name: Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer
License: Public Domain

Leiden University Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent ovarian cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 256873
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.